Latest Articles
- Updated guidelines for immune thrombocytopenic purpura: Expanded management options
The aim is to help practitioners decide on inpatient vs outpatient management, thresholds for initiating treatment, and options for second-line treatment in adults.
- SGLT-2 inhibitors are potential game-changers (for more than diabetes)
Data from large clinical trials and improved understanding of the biologic effects of these drugs are changing expectations for the clinical course in patients with diabetes, as well as chronic kidney disease and heart failure.
- Elevated hCG can be a benign finding in perimenopausal and postmenopausal women
A search for the source of the elevation in perimenopausal and postmenopausal women who are not pregnant and have no disease or tumor may delay patient care.
- DXA and clinical challenges of fracture risk assessment in primary care
Overdependence on dual-energy x-ray absorptiometry, especially for patient populations the test was not designed for, may lead to poor clinical decisions.
- SGLT-2 inhibitors in heart failure: Time for broader eligibility and earlier initiation
SGLT-2 inhibitors remain vastly underused in clinical practice despite their broad cardiorenal benefits.
- Gastrointestinal varicella-zoster virus infection
Esophagogastroduodenoscopy showed small, shallow ulcers and erosions surrounded by red haloes, spread diffusely throughout the stomach and duodenum.
- Spontaneous coronary artery dissection: Principles of management
Once thought to be rare, it is increasingly recognized as a common cause of acute coronary syndrome, particularly in young women.
- Generalized acute cutaneous lupus erythematosus in a young female
A history of systemic lupus and discontinuation of medications for 3 months led to increased disease activity.
- Should my older adult patients take aspirin for primary prevention of cardiovascular disease?
For patients age 70 and older, recent evidence shows that the harms outweigh the benefits.
Another influenza season in the shadow of the COVID-19 pandemicFlu season is upon us at the ominous milestone of more than 722,000 US deaths from COVID-19.
